There is always something new right around the corner. . .

I have been following this company for quite a while and their work is looking very promising. The company's name is Imugene and here is a link to them:

Imugene (ASX: IMU)

and their clinical trails:

Clinical Trials — Imugene (ASX: IMU)

I would love to see some of these in 3rd phase trials.

I try to stay positive, but I am currently in one of those dips where I see it as nothing seems to reach 3rd phase.

I do know these down feelings pass, but it sure is hard when you are in one.

I rhink that is the same one I posted. I get that it was a really small trial, but WOW! I wonder if they can figure out a way for it to work for those without that specific mutation.

Yes, although it makes me sad that I am on a last line drug and there is no miracle in the works for me.